Mills KHG - Search Results

1

Metabolic reprogramming of natural killer cells in obesity limits antitumor responses.

Michelet X, Dyck L, Hogan A, Loftus RM, Duquette D, Wei K, Beyaz S, Tavakkoli A, Foley C, Donnelly R, O'Farrelly C, Raverdeau M, Vernon A, Pettee W, O'Shea D, Nikolajczyk BS, Mills KHG, Brenner MB, Finlay D, Lynch L. Michelet X, et al. Among authors: mills khg. Nat Immunol. 2018 Dec;19(12):1330-1340. doi: 10.1038/s41590-018-0251-7. Epub 2018 Nov 12. Nat Immunol. 2018. PMID: 30420624

2

Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells.

Byrne P, McGuirk P, Todryk S, Mills KH. Byrne P, et al. Eur J Immunol. 2004 Sep;34(9):2579-88. doi: 10.1002/eji.200425092. Eur J Immunol. 2004. PMID: 15307190 Free article.

3

Regulatory T cells: friend or foe in immunity to infection?

Mills KH. Mills KH. Nat Rev Immunol. 2004 Nov;4(11):841-55. doi: 10.1038/nri1485. Nat Rev Immunol. 2004. PMID: 15516964 Review.

4

Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics.

Jarnicki AG, Conroy H, Brereton C, Donnelly G, Toomey D, Walsh K, Sweeney C, Leavy O, Fletcher J, Lavelle EC, Dunne P, Mills KH. Jarnicki AG, et al. J Immunol. 2008 Mar 15;180(6):3797-806. doi: 10.4049/jimmunol.180.6.3797. J Immunol. 2008. PMID: 18322186

5

Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta.

Rowan AG, Fletcher JM, Ryan EJ, Moran B, Hegarty JE, O'Farrelly C, Mills KH. Rowan AG, et al. J Immunol. 2008 Oct 1;181(7):4485-94. doi: 10.4049/jimmunol.181.7.4485. J Immunol. 2008. PMID: 18802051

6

CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.

Fletcher JM, Lonergan R, Costelloe L, Kinsella K, Moran B, O'Farrelly C, Tubridy N, Mills KH. Fletcher JM, et al. J Immunol. 2009 Dec 1;183(11):7602-10. doi: 10.4049/jimmunol.0901881. Epub 2009 Nov 16. J Immunol. 2009. PMID: 19917691

7

Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.

Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, Sharp FA, Becker C, Franchi L, Yoshihara E, Chen Z, Mullooly N, Mielke LA, Harris J, Coll RC, Mills KH, Mok KH, Newsholme P, Nuñez G, Yodoi J, Kahn SE, Lavelle EC, O'Neill LA. Masters SL, et al. Nat Immunol. 2010 Oct;11(10):897-904. doi: 10.1038/ni.1935. Epub 2010 Sep 12. Nat Immunol. 2010. PMID: 20835230 Free PMC article.

8

TLR-dependent T cell activation in autoimmunity.

Mills KH. Mills KH. Nat Rev Immunol. 2011 Nov 18;11(12):807-22. doi: 10.1038/nri3095. Nat Rev Immunol. 2011. PMID: 22094985 Review.

9

Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells.

Conroy H, Galvin KC, Higgins SC, Mills KH. Conroy H, et al. Cancer Immunol Immunother. 2012 Mar;61(3):425-31. doi: 10.1007/s00262-011-1188-y. Epub 2011 Dec 23. Cancer Immunol Immunother. 2012. PMID: 22193988 Free PMC article.

10

Therapeutic potential of targeting IL-17.

Jones SA, Sutton CE, Cua D, Mills KH. Jones SA, et al. Nat Immunol. 2012 Nov;13(11):1022-5. doi: 10.1038/ni.2450. Nat Immunol. 2012. PMID: 23080193

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

243 results

Search Page